FDA approves Zyrtec OTC
Executive Summary
The agency approves allergy treatment Zyrtec (cetirizine) for nonprescription use, one week after it granted Johnson & Johnson approval to switch the decongestant combination product, Zyrtec-D. The prescription-strength product will be available OTC in stores starting in late January 2008, J&J says in a Nov. 16 release...
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.